TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Preserve NCI’s Role In Applied Research And Its Unique Environment, Chabner Says May 12, 1995